KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Profit After Tax (2016 - 2025)

Astrana Health's Profit After Tax history spans 16 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Profit After Tax fell 93.31% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $10.2 million, down 81.29%, while the annual FY2024 figure was $43.1 million, 25.41% down from the prior year.
  • Profit After Tax for Q3 2025 was $1.1 million at Astrana Health, down from $9.9 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $34.3 million in Q3 2021 and bottomed at -$14.0 million in Q4 2021.
  • The 5-year median for Profit After Tax is $12.1 million (2022), against an average of $11.3 million.
  • The largest annual shift saw Profit After Tax soared 256.81% in 2021 before it plummeted 7294.68% in 2024.
  • A 5-year view of Profit After Tax shows it stood at -$14.0 million in 2021, then skyrocketed by 77.5% to -$3.2 million in 2022, then skyrocketed by 97.02% to -$94000.0 in 2023, then tumbled by 7294.68% to -$7.0 million in 2024, then skyrocketed by 115.49% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Profit After Tax are $1.1 million (Q3 2025), $9.9 million (Q2 2025), and $6.2 million (Q1 2025).